SHANGHAI TANGRUN PHARMACEUTICALS CO LTD has a total of 18 patent applications. Its first patent ever was published in 2010. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are DONG A SOCIO HOLDINGS CO LTD, INOTEK CORP and YUHAN CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | EPO (European Patent Office) | 1 | |
#4 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Zhang Suoming | 12 |
#2 | Wang Shun | 3 |
#3 | Luan Weili | 3 |
#4 | Zhang Suo Ming | 2 |
#5 | Wang Han | 1 |
#6 | Han Wang | 1 |
#7 | Yu Wenqing | 1 |
#8 | Long Guoying | 1 |
#9 | Shi Xia | 1 |
#10 | Guoying Long | 1 |
Publication | Filing date | Title |
---|---|---|
CN106279322A | The nucleoside compound of anti-hepatitis C virus and application thereof | |
CN104447952A | Hepatitis C virus protease inhibitor and synthesis method thereof | |
CN105272972A | Benzoheterocyclic hexadiene derivative having anti-virus activity | |
CN104610272A | Annular flavonoids or isoflavonoid and application thereof | |
CN104557954A | Anti-HCV (hepatitis c virus) macrocyclic compound | |
CN103980259A | Flavonoids or isoflavone compound and use thereof | |
WO2013017026A1 | Hcv protease inhibitors | |
WO2010145523A1 | Compounds having activity of anti-hcv and uses thereof | |
WO2010148963A1 | Compounds having activity against hepatitis virus and use thereof |